Christine Poon

Track

Insider profile

Currently holds positions in Prudential Financial Inc, Regeneron Pharmaceuticals, Inc., Sherwin-Williams Co and Koninklijke Philips NV

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 77% 68% 82%
Transactions
27 4% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Prudential Financial Inc Sept. 1, 2006 -
Independent Director Regeneron Pharmaceuticals, Inc. Nov. 12, 2010 -
Independent Director Sherwin-Williams Co Jan. 1, 2014 -
Independent Vice Chairman of the Supervisory Board, Secretary Koninklijke Philips NV Jan. 1, 2014 -
Member of the Supervisory Board Koninklijke Philips NV March 27, 2009 - Jan. 1, 2014
Christine Poon's trades of Regeneron Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
74.35
Quantity 1,350 +inf%
Value US$100,372
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-11-02 2026-11-02
PrS Proposed sale
13,667
355.28
US$3,947,300 		13,667 355.28 US$3,947,300
2025-10-31 2025-10-29
S Sale
36,609 -37.8%
384.09
US$3,513,462 		36,609 -37.8% 384.09 US$3,513,462
2025-10-31 2025-10-29
S Sale
98,480 -47.6%
328.60
US$2,040,648 		98,480 -47.6% 328.60 US$2,040,648
2025-10-31 2025-10-29
S Sale
100 -2.8%
655.10
US$65,510 		100 -2.8% 655.10 US$65,510
2025-10-31 2025-10-29
S Sale
1,915 -35.0%
654.42
US$1,253,214 		1,915 -35.0% 654.42 US$1,253,214
2025-10-31 2025-10-29
S Sale
2,735 -33.3%
653.50
US$1,787,322 		2,735 -33.3% 653.50 US$1,787,322
2025-10-31 2025-10-29
S Sale
650 -7.3%
652.68
US$424,242 		650 -7.3% 652.68 US$424,242
2025-10-29 2025-10-29
PrS Proposed sale
6,500
652.91
US$4,243,915 		6,500 652.91 US$4,243,915
2024-08-19 2024-08-15
S Sale
100 -4.4%
1,161.32
US$116,132 		100 -4.4% 1,161.32 US$116,132
2024-08-19 2024-08-15
S Sale
234 -9.3%
1,160.45
US$271,545 		234 -9.3% 1,160.45 US$271,545
2024-08-19 2024-08-15
S Sale
5,352 -68.1%
1,159.56
US$6,205,965 		5,352 -68.1% 1,159.56 US$6,205,965
2024-08-19 2024-08-15
S Sale
212 -2.6%
1,158.02
US$245,500 		212 -2.6% 1,158.02 US$245,500
2024-08-19 2024-08-15
S Sale
1,560 -16.2%
1,157.33
US$1,805,435 		1,560 -16.2% 1,157.33 US$1,805,435
2024-08-19 2024-08-15
S Sale
2,368 -19.7%
1,156.30
US$2,738,118 		2,368 -19.7% 1,156.30 US$2,738,118
2024-08-19 2024-08-15
S Sale
1,012 -7.8%
1,155.72
US$1,169,589 		1,012 -7.8% 1,155.72 US$1,169,589
2024-08-15 2024-08-15
PrS Proposed sale
10,838
1,156.86
US$12,538,049 		10,838 1,156.86 US$12,538,049
2023-08-25 2023-08-23
S Sale
500 -19.7%
841.05
US$420,525 		500 -19.7% 841.05 US$420,525
2023-08-25 2023-08-23
S Sale
6,450 -71.8%
840.65
US$5,422,192 		6,450 -71.8% 840.65 US$5,422,192
2023-08-25 2023-08-23
S Sale
3,032 -25.2%
839.45
US$2,545,212 		3,032 -25.2% 839.45 US$2,545,212
2023-08-25 2023-08-23
S Sale
1,998 -14.3%
838.60
US$1,675,523 		1,998 -14.3% 838.60 US$1,675,523
2023-08-25 2023-08-23
S Sale
300 -2.1%
837.92
US$251,376 		300 -2.1% 837.92 US$251,376
2023-08-23 2023-08-23
PrS Proposed sale
12,280
840.63
US$10,322,936 		12,280 840.63 US$10,322,936
2022-08-11 2022-08-09
S Sale
8,186 -81.4%
621.27
US$5,085,716 		8,186 -81.4% 621.27 US$5,085,716
2022-08-11 2022-08-09
S Sale
6,814 -40.4%
620.47
US$4,227,883 		6,814 -40.4% 620.47 US$4,227,883
2020-08-31 2020-08-28
S Sale
693 -32.6%
603.20
US$418,018 		693 -32.6% 603.20 US$418,018
2020-08-31 2020-08-28
S Sale
12,899 -85.9%
602.39
US$7,770,229 		12,899 -85.9% 602.39 US$7,770,229
2020-08-31 2020-08-28
S Sale
8,011 -34.8%
601.53
US$4,818,857 		8,011 -34.8% 601.53 US$4,818,857
2020-08-31 2020-08-28
S Sale
12,490 -35.2%
600.44
US$7,499,496 		12,490 -35.2% 600.44 US$7,499,496
2020-08-31 2020-08-28
S Sale
5,730 -13.9%
599.67
US$3,436,109 		5,730 -13.9% 599.67 US$3,436,109
2020-08-31 2020-08-28
S Sale
177 -0.4%
598.91
US$106,007 		177 -0.4% 598.91 US$106,007
2008-05-15 2008-05-14
B Purchase
1,350 +inf%
74.35
US$100,372 		1,350 +inf% 74.35 US$100,372